Objective  To explore training programs for pharmacists in retail pharmacies to implement medication therapy management services for patients with chronic diseases.

Methods  Combined with national conditions in China, the expert consultation method was used to establish a training program for pharmacists in retail pharmacies on chronic disease medication therapy management in terms of curriculum setting, teaching mode, and teaching assessment, and to implement the training. Qualitative interviews were conducted to gain an in-depth understanding of pharmacists' evaluations and suggestions on the training program.

Results  The training curriculum covered practice skills of pharmaceutical care and pharmacotherapeutics. The teaching modes included online learning and Q&A, case writing, role-playing and standardized patient case practices, and teaching assessment was conducted through knowledge quizzes, objective structured clinical exams, practice tests and questionnaires. 181 pharmacists attended and completed the training, and the score of their overall satisfaction with the training program was 4.7 (out of a maximum score of 5.0). Through the training, pharmacists' knowledge and skill levels in medication therapy management as well as attitudes, confidence and perceptions of practice were significantly improved and demonstrated better pharmacy practice abilities. Most pharmacists expressed their learning needs for disease-based pharmacy service model and  communication skills training with patients in qualitative interviews.

Conclusion  A training program suitable for retail pharmacists to improve the comprehensive ability of chronic disease medication therapy management has initially formed, and disease-based doctor-patient communication ability and pharmaceutical care process training should become the focus of learning in medication therapy management service ability of retail pharmacists.

1.袁天蔚, 阮梅花, 朱成姝, 等. 2023年慢性病防控领域发展态势[J]. 生命科学, 2024, 36(1): 30-38. [Yuan  TW, Ruan MH, Zhu CS, et al. Progress of prevention and control of chronic diseases in 2023[J]. Chinese Bulletin of Life Sciences, 2024, 36(1): 30-38.] DOI: 10.13376/j.cbls/2024005.

2.Mcgivney MS, Meyer SM, Duncan-hewitt W, et al. Medication therapy management: its relationship to patient counseling, disease management, and pharmaceutical care  [J]. J Am Pharm Assoc (2003) , 2007, 47(5): 620-628. DOI: 10.1331/JAPhA.2007.06129.

3.Anderegg MD, Gums TH, Uribe L, et al. Pharmacist intervention for blood pressure control in patients with diabetes and/or chronic kidney disease[J]. Pharmacotherapy, 2018, 38(3): 309-318. DOI: 10.1002/phar.2083.

4.Suhadi R, Virginia DM, setiawan CH. The effect of health education by pharmacists on 10-year atherosclerotic cardiovascular disease risk: a cluster-randomized control study in a low socioeconomic status Javanese population[J]. J Prim Care Community Health, 2018, 9: 2150132718773674. DOI: 10.1177/2150132718773674.

5.国家药品监督管理局. 国家药监局关于印发执业药师注册管理办法的通知[EB/OL]. (2021-06-24) [2024-07-27]. https://www.nmpa.gov.cn/xxgk/fgwj/xzhgfxwj/20210624111721125.html.

6.国家药品监督管理局执业药师资格认证中心. 《执业药师业务规范》[EB/OL]. (2017-03-02) [2024-07-27]. http://www.cqlp.org/info/link.aspx?id=3213&page=1h.

7.张笑雨. 国药控股(湖北): 慢病管理新突破[J]. 中国药店, 2017, (6): 68-70. DOI: CNKI:SUN:YDZZ.0.2017-06- 029.

8.李明洙, 张茜, 于东港, 等. 广东某药店利用MTM-AI系统开展慢病管理的案例研究[J]. 中国药业, 2018, 27(18): 76-9. [Li MZ, Zhang Q, Yu DG, et al. A case study of chronic disease management by using MTM-AI system in a drugstore in Guangdong province[J]. China Pharmaceuticals, 2018, 27(18): 76-79.] DOI: 10.3969/j.issn.1006-4931.2018.18.025.

9.何丹. 合肥市零售药店执业药师药学服务现状-基于顾客需求的研究[D]. 合肥: 安徽医科大学, 2019. https://cdmd.cnki.com.cn/Article/CDMD-10366-1019173819.htm.

10.Wang J, Pei Y, Yu F, et al. Understandings, attitudes, and barriers about diabetes care: analysis of factors influencing community pharmacists in China[J]. Diabetes Metab Syndr Obes, 2021, 14: 1999-2009. DOI: 10.2147/DMSO.S304066.

11.蒋蓉, 朱佳文, 邵蓉. 我国31个省份执业药师继续教育管理与实施方式比较研究[J]. 中国药房, 2022, 33(15): 1887-1892. [Jiang R, Zhu JW, Shao R. Comparative study on the management and implementation of continuing education for licensed pharmacists in 31 provinces of China[J]. China Pharmacy, 2022, 33(15): 1887-1892.] DOI: 10.6039/j.issn.1001-0408.2022.15.18.

12.朱佳文, 蒋蓉, 丁瑞琳, 等. 英国执业药师继续教育体系分析及对我国的启示[J]. 中国药房, 2021, 32(5): 530-535. [Zhu JW, Jiang R, Ding RL et al. Analysis of the continuing education system for licensed pharmacists in the uk and its enlightenment to China[J]. China Pharmacy, 2021, 32(5): 530-535.] DOI: 10.6039/j.issn.1001-0408. 2021.05.04.

13.(美)罗伯特J.奇波利(Robert J. Cipolle), 琳达M.斯特兰德(Linda M. Strand), 彼得C. 莫利(Peter C. Morley), 著. 康震, 金有豫, 朱珠, 等, 译. 药学监护实践方法(以患者为中心的药物治疗管理服务原著第3版)[M]. 北京: 化学工业出版社, 2016: 38-40.

14.闫素英. 中国药物治疗管理培训与实践专家共识[J]. 临床药物治疗杂志, 2020, 18(3): 21-25. [Yan SY. Expert consensus on medication therapy management training and practice in China[J]. Clinical Medication Journal, 2020, 18(3): 21-25.] DOI: CNKI:SUN:LCYW.0.2020-03-005.

15.Yardley S, Dornan T. Kirkpatrick's levels and education 'evidence'[J]. Med Educ, 2012, 46(1): 97-106. DOI: 10.1111/j.1365-2923.2011.04076.x.

16.廖倩文, 胡源晖, 裴毓瑶, 等. 药学监护技能评估标准的建立及在教学中的应用[J]. 中国医院药学杂志, 2022, 42(20): 2182-2187. [Liao QW, Hu YH, Pei YY et al. Establishment and application of assessment criteria of pharmaceutical care skills in teaching[J]. Chinese Journal of Hospital Pharmacy, 2022, 42(20): 2182-2187.] DOI: 10.13286/j.1001-5213.2022.20.20.

17.顾红燕, 李达, 袁瑞玲, 等. 药物治疗管理服务培训的教学探索与实践[J]. 临床药物治疗杂志, 2018, 16(11): 10-14. [Gu HY, Li D, Yuan RL et al. Teaching exploration and practice on medication therapy management service[J]. Clinical Medication Journal, 2018, 16(11): 10-14.] DOI: 10.3969/j.issn.1672-3384.2018.11.003.

18.四川省执业药师协会. 关于开展社会药房药物治疗管理(药物治疗管理)第二期培训班的通知[EB/OL]. (2021-10-09) [2024-07-27]. https://www.sclpa.cn/newinfo/xhdt_content.aspx?id=2583.

19.新疆药学会. 关于举办2020年药物治疗管理(药物治疗管理)培训项目(第一期)的通知[EB/OL]. (2020-06-09) [2024-07-27]. http://xjyxh.com/xjyxh/article.asp?articleid=272.

20.Al-Tameemi NK, Sarriff A. Knowledge, attitude and practice of pharmacists on medication therapy management: a survey in Hospital Pulau Pinang, Penang, Malaysia[J]. J Pharm Health Care Sci, 2019, 5: 1. DOI: 10.1186/s40780-019-0131-9.

21.Macintosh C, Weiser C, Wassimi A, et al. Attitudes toward and factors affecting implementation of medication therapy management services by community pharmacists[J]. J Am Pharm Assoc (2003), 2009, 49(1): 26-30. DOI: 10.1331/JAPhA.2009.07122.

22.陈小洁, 王秀苇, 夏良存. SOAP模式门诊药历在药学服务质量中的作用[J]. 中医药管理杂志, 2021, 29(12): 153-154. [Chen XJ, Wang XW, Xia L. The role of SOAP model outpatient medical records in the quality of pharmacy services[J]. Journal of Traditional Chinese Medicine Management, 2021, 29(12): 153-154.] DOI: 10.16690/j.cnki.1007-9203.2021.12.072.

23.中华医学会糖尿病学分会, 国家基层糖尿病防治管理办公室. 国家基层糖尿病防治管理指南(2022)[J]. 中华内科杂志, 2022, (3): 249-262. DOI: 10.3760/cma.j.cn112138-20220120-000063.

24.Yong FR, Hor SY, Bajorek BV. Australian community pharmacy service provision factors, stresses and strains: a qualitative study [J]. Explor Res Clin Soc Pharm, 2023, 9: 100247. DOI: 10.1016/j.rcsop.2023.100247.

25.Meyerson BE, Agley JD, Jayawardene W, et al. Feasibility and acceptability of a proposed pharmacy-based harm reduction intervention to reduce opioid overdose, HIV and hepatitis C[J]. Res Social Adm Pharm, 2020, 16(5): 699-709. DOI: 10.1016/j.sapharm.2019.08.026.

26.Cochran G, Chen Q, Field C, et al. A community pharmacy-led intervention for opioid medication misuse: a small-scale randomized clinical trial[J]. Drug Alcohol Depend, 2019, 205: 107570. DOI: 10.1016/j.drugalcdep.2019.107570.

27.Horsfield E, Sheridan J, Anderson C. What do community pharmacists think about undertaking screening and brief interventions with problem drinkers? Results of a qualitative study in New Zealand and England[J]. Int J Pharm Pract, 2011, 19(3): 192-200. DOI: 10.1111/j.2042-7174.2011.00112.x.

28.Laliberté MC, Perreault S, Damestoy N, et al. Ideal and actual involvement of community pharmacists in health promotion and prevention: a cross-sectional study in Quebec, Canada [J]. BMC Public Health, 2012, 12: 192. DOI: 10.1186/1471-2458-12-192.